CIK 0001830487 · Large accelerated filer
Pharvaris N.V.
Sign in to watch- Ticker
- PHVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- other
- Phone
- 31 (0)71 203 6410
- Business address
- J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
- Former names
- Pharvaris, B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,335,217
- in 16 filings, $4.1M under 10b5-1 plans
Net −$20,335,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Schikan Johannes Gerardus Christiaan Petrus −$7.0M Director sold 64% of stake
- Lu Peng −$4.7M President sold 67% of stake
- Bjork Elisabeth −$2.0M Director sold 78% of stake
- Lesage Anne −$1.9M Chief Early Development sold 40% of stake
- Abele Stefan Andreas −$1.8M Chief Technical Ops Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Lu Peng President | Shares withheld for taxes | −117 | $34.18 | $4K | 109,809 |
| 2026-11-11 | Lu Peng President | Shares withheld for taxes | −109 | $33.99 | $4K | 109,926 |
| 2026-10-12 | Lu Peng President | Shares withheld for taxes | −117 | $31.10 | $4K | 110,035 |
| 2026-10-11 | Lu Peng President | Shares withheld for taxes | −109 | $31.10 | $3K | 110,152 |
| 2026-09-23 | Monges Viviane Director | Option exercise | +11,969 | $8.05 | $96K | 17,469 |
| 2026-09-23 | Monges Viviane Director | Sale | −11,969 | $33.05 | $396K | 5,500 |
| 2026-09-23 | Monges Viviane Director | Option exercise · Stock Option (Right to Buy) | −11,969 | 9,031 | ||
| 2026-09-22 | Lu Peng President | Option exercise | +45,308 | $2.59 | $117K | 110,261 |
| 2026-09-22 | Lu Peng President | Option exercise · Stock Option (Right to Buy) | −45,308 | 0 | ||
| 2026-09-22 | Schikan Johannes Gerardus Christiaan Petrus Director | Option exercise | +800 | $20.00 | $16K | 115,967 |
| 2026-09-22 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | −800 | $36.19 | $29K | 115,167 |
| 2026-09-22 | Schikan Johannes Gerardus Christiaan Petrus Director | Option exercise · Stock Option (Right to Buy) | −800 | 34,200 | ||
| 2026-09-21 | Nassif David W. CFO / CLO | Sale | −6,000 | $36.47 | $219K | 114,300 |
| 2026-09-21 | Nassif David W. CFO / CLO | Gift | −500 | 113,800 | ||
| 2026-09-17 | Lu Peng President | Option exercise | +100,000 | $2.59 | $259K | 164,953 |
| 2026-09-17 | Lu Peng President | Sale | −100,000 | $35.00 | $3.5M | 64,953 |
| 2026-09-17 | Lu Peng President | Option exercise · Stock Option (Right to Buy) | −13,308 | 0 | ||
| 2026-09-17 | Lu Peng President | Option exercise · Stock Option (Right to Buy) | −86,692 | 45,308 | ||
| 2026-09-17 | Schikan Johannes Gerardus Christiaan Petrus Director | Sale | −200,000 | $35.00 | $7.0M | 115,167 |
| 2026-09-17 | Bjork Elisabeth Director | Option exercise | +35,000 | $14.39 | $504K | 50,167 |
Page 1 of 9 · 170 trades